Unlike CCL2, the release of CCL5 by tumor cells not only promotes TAMs and MDSCs infiltration, participating in tumor metastasis [27],but also recruits CD8 + T cells to enhance adaptive immunity. The gene discussed is CCL5; the disease is neoplasm.